Company / Assets per Share
Travere Therapeutics, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$6.92
FY2025
5-year range
$6.92 / $14.86
FY2021-FY2025
Trend
-12.2%
vs FY2024
Sector context
#126 of 210
Health Care
What the data says
At $6.92, Travere Therapeutics, Inc.'s assets per share ranks #126 of 210 in the Health Care sector. Assets per Share has fluctuated over the past 10 years, ranging from $6.92 in FY2025 to $18.01 in FY2018.
Based on SEC 10-K filings.
6.92 in FY2025 with a 5-year CAGR of -13.3%.
Declined from $12.27 to $6.92 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -13.7%
- 5-Year CAGR
- -13.3%
- 10-Year CAGR
- -
Sector benchmark
#126 of 210 in Health CareTop 60% of 210This company $6.92 Sector average $353.15
▼
-98.0% below sector average
Key checks
Key Insights
- In FY2025, assets per share decreased 12.2% year-over-year.
- Ranks #126 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.92 | -12.2% |
| FY2024 | $7.88 | -35.8% |
| FY2023 | $12.27 | +14.0% |
| FY2022 | $10.76 | -27.6% |
| FY2021 | $14.86 | +5.4% |
| FY2020 | $14.10 | -3.5% |
| FY2019 | $14.61 | -18.9% |
| FY2018 | $18.01 | +31.2% |
| FY2017 | $13.73 | -4.7% |
| FY2016 | $14.40 | -26.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026